---
phase: 60-foundation-encounterid-propagation-and-drug-name-resolution
plan: 03
subsystem: data-pipeline
tags: [R, drug-name-resolution, rxnorm, encounter-id, gantt-export, openxlsx2]

# Dependency graph
requires:
  - phase: 60-01
    provides: ENCOUNTERID extraction and encounter_ids aggregation in R/44a
  - phase: 60-02
    provides: drug_name_lookup.rds with RxNorm API lookups
provides:
  - Drug name join to episode detail (treatment_episodes.rds and treatment_episode_detail.rds)
  - Drug names aggregated per episode (comma-separated unique names)
  - Gantt CSV exports with encounter_ids, drug_names, ENCOUNTERID, drug_name columns
  - Phase 60 audit xlsx (3 sheets: ENCOUNTERID rates, SCT audit, drug name resolution)
affects: [phase-61-episode-classification, gantt-visualization, regimen-detection]

# Tech tracking
tech-stack:
  added: []
  patterns: ["Drug name join via left_join on triggering_code = code", "Per-episode drug name aggregation via group_by and paste(sort(unique()))", "Audit xlsx with three sheets for Phase 60 validation"]

key-files:
  created:
    - output/phase_60_audit.xlsx
  modified:
    - R/44a_treatment_episodes.R
    - R/49_gantt_data_export.R

key-decisions:
  - "Drug name join via left_join on triggering_code = code from drug_name_lookup.rds"
  - "Per-episode drug_names aggregated as comma-separated sorted unique drug names"
  - "Phase 60 audit xlsx documents ENCOUNTERID population rates, SCT source audit, and drug name resolution summary"
  - "Gantt pseudo-treatment rows (Death, HL Diagnosis) include new columns with empty/NA values"

patterns-established:
  - "Pattern 1: Drug name resolution via external lookup table joined on triggering_code"
  - "Pattern 2: Per-episode drug name aggregation via comma-separated unique sorted list"
  - "Pattern 3: Multi-sheet audit xlsx for phase validation with RDS artifact sources"

requirements-completed: [TREAT-04]

# Metrics
duration: 22min
completed: 2026-05-30
---

# Phase 60 Plan 03: Drug Name Join & Gantt Export Summary

**Drug name resolution joined to episode detail, aggregated per episode, and propagated to Gantt CSVs with encounter IDs for regimen identification**

## Performance

- **Duration:** 22 min
- **Started:** 2026-05-30T02:50:02Z
- **Completed:** 2026-05-30T02:54:15Z
- **Tasks:** 2
- **Files modified:** 2

## Accomplishments
- Drug names from drug_name_lookup.rds joined to treatment_episode_detail.rds via left_join on triggering_code
- Per-episode drug_names aggregated as comma-separated unique sorted drug names in treatment_episodes.rds
- Gantt CSVs export with encounter_ids, drug_names, ENCOUNTERID, drug_name columns (TREAT-04 complete)
- Phase 60 audit xlsx documents ENCOUNTERID population rates, SCT source audit, and drug name resolution summary
- Death and HL Diagnosis pseudo-treatment rows include new columns with appropriate empty/NA values

## Task Commits

Each task was committed atomically:

1. **Task 1: Add drug name join to R/44a and produce Phase 60 audit xlsx** - `fea1a62` (feat)
2. **Task 2: Propagate encounter_ids, drug_names, ENCOUNTERID, drug_name to Gantt CSVs** - `d1ca3f7` (feat)

## Files Created/Modified
- `R/44a_treatment_episodes.R` - Added Section 5B for drug name join and aggregation, Section 7B for phase_60_audit.xlsx creation, updated CSV/xlsx output to include drug_names and drug_name columns
- `R/49_gantt_data_export.R` - Updated expected columns, main exports, Death/HL Diagnosis pseudo-treatment rows, and summary stats to include encounter_ids, drug_names, ENCOUNTERID, drug_name
- `output/phase_60_audit.xlsx` - Three-sheet audit workbook (ENCOUNTERID Rates, SCT Source Audit, Drug Name Resolution)

## Decisions Made

**1. Drug name join strategy**
- Used left_join on triggering_code = code from drug_name_lookup.rds
- Preserves all detail rows; drug_name = NA when code not in lookup table
- Rationale: Maintains full episode detail fidelity while enriching with drug names where available

**2. Per-episode drug name aggregation**
- Aggregated as comma-separated sorted unique drug names via paste(sort(unique(drug_name)), collapse = ",")
- Alphabetical sort for reproducibility (Claude's discretion, consistent with triggering_codes pattern)
- Empty string for episodes with no drug names (not NA)
- Rationale: Matches existing triggering_codes pattern, queryable per-episode drug list

**3. Phase 60 audit xlsx structure**
- Sheet 1: ENCOUNTERID population rates by source table (from encounterid_profile.rds)
- Sheet 2: SCT source audit (pre/post ICD DX code removal comparison from sct_audit_result.rds)
- Sheet 3: Drug name resolution summary (success/not found/errors) + full lookup table
- Rationale: Single consolidated audit workbook for Phase 60 validation

**4. Pseudo-treatment row handling**
- Death and HL Diagnosis rows include encounter_ids = "", drug_names = ""
- Death and HL Diagnosis detail rows include ENCOUNTERID = NA_character_, drug_name = NA_character_
- Rationale: Maintains column alignment for bind_rows without introducing spurious data

## Deviations from Plan

None - plan executed exactly as written.

## Issues Encountered

None - all tasks executed as specified in PLAN.md.

## User Setup Required

None - no external service configuration required.

## Next Phase Readiness

- Drug names now available in treatment_episode_detail.rds for regimen detection (Phase 61)
- Encounter IDs available in treatment_episodes.rds for encounter-level cancer linkage (Phase 61)
- Gantt CSVs include all new columns for Phase 61 enhanced visualization
- Phase 60 audit xlsx provides validation baseline for ENCOUNTERID population rates and drug name resolution

**Ready for Phase 61:** Episode classification with encounter-level cancer linkage and regimen detection.

---
*Phase: 60-foundation-encounterid-propagation-and-drug-name-resolution*
*Completed: 2026-05-30*
